Insulin resistance and reduced metabolic flexibility: Cause or consequence of NAFLD?

Clinical Science

Volumn 131, Issue 22, 2017, Pages 2701-2704

  Gastaldelli, Amalia ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; INSULIN;

AEROBIC METABOLISM; AUTOREGULATION; CALORIC INTAKE; EDITORIAL; GLUCONEOGENESIS; HUMAN; HYPERGLYCEMIA; INSULIN INFUSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; ADIPOSE TISSUE; ANIMAL; BLOOD; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; GENETIC PREDISPOSITION; GENETICS; GLUCOSE BLOOD LEVEL; LIVER; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PHENOTYPE; PROGNOSIS; RISK FACTOR; SIGNAL TRANSDUCTION;

ADIPOSE TISSUE; ANIMALS; BIOMARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSULIN; INSULIN RESISTANCE; LIVER; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PHENOTYPE; PROGNOSIS; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 85033550528     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20170987     Document Type: Editorial

References (21)

1. Chalasani, N., Younossi, Z., Lavine, J.E., Diehl, A.M., Brunt, E.M., Cusi, K. et al. (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55, 2005-2023
2. Marchesini, G., Day, C.P., Dufour, J.-F., Canbay, A., Nobili, V., EASL et al. (2016) EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J. Hepatol. 64, 1388-1402
3. Younossi, Z.M., Koenig, A.B., Abdelatif, D., Fazel, Y., Henry, L. and Wymer, M. (2016) Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64, 73-84
4. Lallukka, S. and Yki-Jarvinen, H. (2016) Non-alcoholic fatty liver disease and risk of type 2 diabetes. Best Pract. Res. Clin. Endocrinol. Metab. 30, 385-395
5. Saponaro, C., Gaggini, M., Carli, F. and Gastaldelli, A. (2015) The subtle balance between lipolysis and lipogenesis: a critical point in metabolic homeostasis. Nutrients 7, 9453-9474
6. Gastaldelli, A., Cusi, K., Pettiti, M., Hardies, J., Miyazaki, Y., Berria, R. et al. (2007) Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterology 133, 496-506
7. Bugianesi, E., Gastaldelli, A., Vanni, E., Gambino, R., Cassader, M., Baldi, S. et al. (2005) Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia 48, 634-642
8. Brouwers, B., Schrauwen-Hinderling, V.B., Jelenik, T., Gemmink, A., Havekes, B., Bruls, Y. et al. (2017) Metabolic disturbances of non-alcoholic fatty liver resemble the alterations typical for type 2 diabetes. Clin. Sci. (Lond.) 131, 1905-1917
9. Gaggini, M., Morelli, M., Buzzigoli, E., DeFronzo, R.A., Bugianesi, E. and Gastaldelli, A. (2013) Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients 5, 1544-1560
10. Gastaldelli, A., Miyazaki, Y., Pettiti, M., Buzzigoli, E., Mahankali, S., Ferrannini, E. et al. (2004) Separate contribution of diabetes, total fat mass, and fat topography to glucose production, gluconeogenesis, and glycogenolysis. J. Clin. Endocrinol. Metab. 89, 3914-3921
11. Hyotylainen, T., Jerby, L., Petaja, E.M., Mattila, I., Jantti, S., Auvinen, P. et al. (2016) Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease. Nat. Commun. 7, 8994
12. Mann, J.P. and Anstee, Q.M. (2017) NAFLD: PNPLA3 and obesity: a synergistic relationship in NAFLD. Nat. Rev. Gastroenterol. Hepatol. 14 (9), 506-507
13. Petaja, E.M. and Yki-Jarvinen, H. (2016) Definitions of normal liver fat and the association of insulin sensitivity with acquired and genetic NAFLD-a systematic review. Int. J. Mol. Sci. 17, pii :E633
14. Dongiovanni, P., Petta, S., Maglio, C., Fracanzani, A.L., Pipitone, R., Mozzi, E. et al. (2015) Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease. Hepatology 61, 506-514
15. Isokuortti, E., Zhou, Y., Peltonen, M., Bugianesi, E., Clement, K., Bonnefont-Rousselot, D. et al. (2017) Use of HOMA-IR to diagnose non-alcoholic fatty liver disease: a population-based and inter-laboratory study. Diabetologia 60 (10), 1873-1882
16. Luukkonen, P.K., Zhou, Y., Sadevirta, S., Leivonen, M., Arola, J., Oresic, M. et al. (2016) Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease. J. Hepatol. 64, 1167-1175
17. Stender, S., Kozlitina, J., Nordestgaard, B.G., Tybjaerg-Hansen, A., Hobbs, H.H. and Cohen, J.C. (2017) Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci. Nat. Genet. 49, 842-847
18. Cuthbertson, D.J., Steele, T., Wilding, J.P., Halford, J.C., Harrold, J.A., Hamer, M. et al. (2017) What have human experimental overfeeding studies taught us about adipose tissue expansion and susceptibility to obesity and metabolic complications? Int. J. Obes. 41, 853-865
19. Knudsen, S.H., Hansen, L.S., Pedersen, M., Dejgaard, T., Hansen, J., Hall, G.V. et al. (2012) Changes in insulin sensitivity precede changes in body composition during 14 days of step reduction combined with overfeeding in healthy young men. J. Appl. Physiol. (1985) 113, 7-15
20. Peterson, C.M., Zhang, B., Johannsen, D.L. and Ravussin, E. (2017) Eight weeks of overfeeding alters substrate partitioning without affecting metabolic flexibility in men. Int. J. Obes. 41, 887-893
21. Kelley, D.E. and Mandarino, L.J. (2000) Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 49, 677-683